- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02580864
Bologna IBD Markers
Predictive Factors of Anti-TNFalfa-induced Deep Remission in Crohn's Disease
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
This trial will be exploratory, open in vitro study on human tissues. 120 patients will be enrolled (Caucasian, male/female,18-65 years old) with moderate-severe active Crohns disease and with indication for anti-TNF therapy according to the normal clinical practice.
Simultaneously, 30 no-IBD controls with no GI disorders, as defined by medical history and standard clinical chemistry values, afferent to the out-patient clinic will be enrolled.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
-
Bologna, Italien, 40138
- Bologna University
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
120 adult patients with moderate-severe active Crohns disease with indication for anti-TNF therapy according to the normal clinical practice
30 no-IBD controls with no GI disorders, as defined by medical history and standard clinical chemistry values, afferent to the out-patient clinic
Beskrivelse
Main Inclusion Criteria for IBD patients:
- Adult patients (Caucasian)
- Moderate-severe active Crohns disease (220≤ CDAI ≤450; blood CRP ≥5 mg/L and/or fecal calprotectin ≥250mg/L)
- Indication for anti-TNF therapy according to the normal clinical practice
- Informed consent signed
Main Exclusion Criteria for IBD patients:
- Changes of Crohns disease treatment gastrointestinal medication (including corticosteroids) within the previous 2 weeks prior to enrollment
- Pregnant or breast-feeding (at index date) female patients
Main Inclusion Criteria for no-IBD controls:
- No-IBD adult controls (Caucasian) with no GI disorders, as defined by medical history and standard clinical chemistry values, afferent to the out-patient clinic
- Informed consent signed
Main Exclusion criteria for no-IBD controls:
- Medical history of digestive diseases
- Digestive, renal or metabolic disease, as determined by the medical visit and sa blood chemistry analysis
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
---|
IBD patients
120 adult patients (Caucasian, male/female,18-65 years old) with moderate-severe active Crohns disease (220≤ CDAI ≤450; blood CRP ≥5 mg/L and/or fecal calprotectin ≥250mg/L) and with indication for anti-TNF therapy according to the normal clinical practice
|
No-IBD patients
30 no-IBD controls with no GI disorders, as defined by medical history and standard clinical chemistry values, afferent to the out-patient clinic
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Number of IBD patients in clinical remission at 12 months
Tidsramme: 12 months
|
|
12 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Number of IBD patients requiring an escalation treatment to be in clinical remission at 12 months
Tidsramme: Baseline vs Baseline + 12 months
|
|
Baseline vs Baseline + 12 months
|
Assess phenotypic traits between IBD patients in clinical remission at 12 months and non-IBD subjects
Tidsramme: Baseline vs Baseline + 12 months
|
|
Baseline vs Baseline + 12 months
|
Assess healthy intra-individual variability of gut microbial activity and dietary behavior in relation to disease development and management
Tidsramme: Baseline
|
|
Baseline
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 13.27.NIHS
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Crohns sygdom
-
Asan Medical CenterIkke rekrutterer endnuCrohns sygdom | Terapeutisk lægemiddelovervågning | Infliximab | Perianal fistel på grund af Crohns sygdom | Magnetic Resonance Novel Index for Fistel Imaging i Crohn's Disease Score